Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.51 USD | -3.46% |
|
-8.61% | -2.99% |
Jun. 13 | Teva sues Corcept over mifepristone 'monopoly' for rare disorder | RE |
Jun. 04 | Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating | MT |